Search for: "Somers v. Somers" Results 181 - 200 of 202
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Feb 2018, 9:01 pm by Neil Cahn
The will provided that Irene was to have the condominium in Somers for her exclusive use and occupancy, free of any rent, until her interest terminated upon remarriage, if the premises ceased to be her principal residence, or if she died. [read post]
2 Aug 2019, 9:10 am by Mike Delikat
” She also noted an upward spike in the number of tips following the Supreme Court’s ruling in Somers v. [read post]
16 Mar 2017, 3:00 am by John Jenkins
Whistleblowers: 9th Circuit Says Dodd-Frank Protects Internal Reporters This Perkins Coie memo reviews the 9th Circuit’s recent decision in Somers v. [read post]
12 Dec 2019, 7:31 pm by anne
The continuing high levels of tips may be attributed to continuing impact from the February 2018 Supreme Court decision in Digital Realty v. [read post]
3 Jul 2018, 11:14 am by Mike Delikat
” Uniform Definition of “Whistleblower” In the wake of Digital Realty Trust, Inc. v. [read post]
22 Jul 2019, 2:49 am by Peter Mahler
Vice Chancellor Travis Laster of the Delaware Court of Chancery recently had such a case before him in Longoria v Somers, C.A. [read post]
22 Jan 2007, 6:22 pm
Companies will still need a license when they want to bring the research into their company laboratories or when they want to develop a product for the market.Given that stem cell research is within the area covered by the exemption of 35 USC 271(e)(1) as interpreted by Merck v. [read post]
22 Mar 2018, 4:31 pm by Kevin LaCroix
Supreme Court’s February 21, 2018 decision in the Digital Realty Trust, Inc. v. [read post]
14 Mar 2018, 12:46 am by Kevin LaCroix
Somers that significantly limits who qualifies as a whistleblower under Dodd-Frank. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
5 Apr 2018, 8:24 am by CFM Admin
FINRA’s specific focus areas for 2018 will include: (i) fraud, particularly microcap fraud schemes that target senior investors; (ii) hiring and supervisory practices for high-risk firms and brokers; (iii) cybersecurity; (iv) anti-money laundering; (v) sales practices and product suitability for specific investors, including the supervisory, compliance, and operational infrastructure firms have put in place with respect to ICOs; and (vi) investor protections related to market… [read post]